To further test the generality of the hypothesis that ASO-mediated inhibition of mTORC2 can suppress seizures across a wide range of causative etiologies, we studied two genetic models of spontaneous recurrent seizures: Kcna1-null mice and a “humanized” MTOR gain-of-function model of epilepsy. The gene discussed is MTOR; the disease is epilepsy.